LONG-TERM RESULTS OF RESECTION FOR LARGE HEPATOCELLULAR-CARCINOMA - A MULTIVARIATE-ANALYSIS OF CLINICOPATHOLOGICAL FEATURES

被引:152
作者
LAI, ECS
NG, IOL
NG, MMT
LOK, ASF
TAM, PC
FAN, ST
CHOI, TK
WONG, J
机构
[1] UNIV HONG KONG,QUEEN MARY HOSP,DEPT PATHOL,HONG KONG,HONG KONG
[2] UNIV HONG KONG,QUEEN MARY HOSP,DEPT MED,HONG KONG,HONG KONG
关键词
D O I
10.1002/hep.1840110516
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recurrent or metastatic disease is frequently en‐countered among patients who have had resection of their primary hepatocellular carcinoma. A retro‐spective study on 117 patients (104 men, 13 women; mean age ± standard deviation: 53.8 ± 12.4 yr) who had hepatectomy for large hepatocellular carcinoma (diameter ≧ 5 cm) was conducted to identify an at‐risk population for tumor recurrence. Disease‐free survival was correlated with 22 clinical (n = 5), serological (n = 2), gross pathological (n = 3) and histological (n = 12) features of the resected specimens using Cox's multivariate regression analysis. Recurrent hepatocel‐lular carcinoma was detected in 74 patients within a median follow‐up period of 13.7 mo. Although 17 patients had extrahepatic disease alone, recurrence was confined to the hepatic remnant in 40 patients. Disease‐free survival rates at 1, 3 and 5 yr were 40%, 19% and 12%, respectively. Two of the five histological parameters isolated, negative resection margin (p <0.01) and encapsulation (p < 0.006), were identified as favorable independent prognostic predictors. When patients with positive margins were excluded from the analysis, repeated calculation showed that encapsu‐lation was the only important determinant. From this analysis, detailed histological study of the resected tumor is seen to be the only satisfactory means for assessing long‐term prognosis. An aggressive approach is warranted among patients with encapsulated tu‐mors. Even with a clear resection margin, adjuvant treatment should be considered for those patients who have unencapsulated lesions.(HEPATOLOGY 1990; 11:815‐818.) Copyright © 1990 American Association for the Study of Liver Diseases
引用
收藏
页码:815 / 818
页数:4
相关论文
共 26 条
  • [1] EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
  • [2] 2-E
  • [3] Eggel H, 1901, BEITR PATHOL ANAT AL, V30, P506
  • [4] HSU HC, 1985, CANCER-AM CANCER SOC, V56, P672, DOI 10.1002/1097-0142(19850801)56:3<672::AID-CNCR2820560340>3.0.CO
  • [5] 2-V
  • [6] HSU HC, 1988, CANCER, V61, P2095, DOI 10.1002/1097-0142(19880515)61:10<2095::AID-CNCR2820611027>3.0.CO
  • [7] 2-H
  • [8] CLINICAL MANAGEMENT OF RECURRENT HEPATOCELLULAR-CARCINOMA AFTER PRIMARY RESECTION
    KANEMATSU, T
    MATSUMATA, T
    TAKENAKA, K
    YOSHIDA, Y
    HIGASHI, H
    SUGIMACHI, K
    [J]. BRITISH JOURNAL OF SURGERY, 1988, 75 (03) : 203 - 206
  • [9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [10] MORPHOLOGICAL AND HISTOLOGICAL FEATURES OF RESECTED HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS IN THE WEST
    KEMENY, F
    VADROT, J
    WU, A
    SMADJA, C
    MEAKINS, JL
    FRANCO, D
    [J]. HEPATOLOGY, 1989, 9 (02) : 253 - 257